Drugs / RVEc
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01317667 | Mar 2011 → Nov 2012 | ricin poisoning | U.S. Army Medical Research and Development Command | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RVEc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01317667 ↗ |
| Modality | Vaccine | “We report the safety and immunogenicity of the ricin vaccine RVEc™ in a Phase 1 (N=30) multiple-dose, open-label, non-placebo-controlled, dose-escalating (20, 50, and 100μg),...” PMID 26546259 ↗ Nov 2015 |